Candel Therapeutics raises $22.5mm through Series C round

15:40 EDT 29 Apr 2019 | Elsevier Business Intelligence

Candel Therapeutics (developing off-the-shelf adenovirus-based cancer immunotherapies) raised $22.5mm through its Series C ro...

Original Article: Candel Therapeutics raises $22.5mm through Series C round


More From BioPortfolio on "Candel Therapeutics raises $22.5mm through Series C round"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...